Minims (Povidone, Iodinated)

Povidone‑iodine releases free iodine when applied to the ocular surface. The iodine penetrates the cell walls of microbes and inactivates essential proteins and nucleic acids, resulting in rapid, broad‑spectrum killing of bacteria, viruses, fungi, and protozoa.

The specific dose and frequency of Minims are determined by the prescribing clinician based on the indication and patient condition. The product is supplied as an ophthalmic solution for topical ocular use, and the prescriber will provide exact instructions.

Safety data for povidone‑iodine ophthalmic use in pregnancy and lactation are limited. It should be used only if clearly needed and after a risk‑benefit assessment by the healthcare professional. Women who are pregnant or breastfeeding should discuss use with their clinician.

To order Minims, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide. After verification of trade or institutional credentials, the sales team will provide pricing, availability, shipping details and any required import documentation.

Minims provides a broad‑spectrum antiseptic effect through iodine, which is effective against bacteria, viruses, fungi and protozoa. Compared with other agents such as chlorhexidine, povidone‑iodine has a rapid onset of action and a well‑established safety profile for short‑term ocular use, though it may cause more transient irritation.

Minims should be stored at room temperature, preferably below 25 °C, in its original container. Protect the solution from direct light and moisture. Keep the bottle tightly closed when not in use and out of reach of children.

Minims is applied topically to the eye as an ophthalmic solution. The prescribed number of drops is instilled onto the ocular surface, typically using a sterile dropper. Patients should follow the prescriber’s instructions regarding frequency and duration of treatment.

Serious risks include severe allergic reactions such as angioedema or anaphylaxis, corneal ulceration or epithelial damage, and significant vision loss if the product is misused. Immediate medical attention is required if any of these symptoms develop.

Minims should not be used by individuals with a known allergy to iodine or povidone‑iodine. It is also contraindicated in patients with active corneal disease where the epithelial barrier is compromised, and it should be avoided in children unless specifically prescribed.